Insist on a genuine clinical evaluation that screens for contraindications rather than a rubber-stamp questionnaire
Health insurers will be well served to begin quantifying GLP-1s cost impact on the portfolio for the short and long term, which will vary by market and product, to determine any necessary premium adjustments or changes to underwriting philosophy
And if you give humans a native sequence of GLP-1 or GIP, they both have a half-life in your body of seven or eight minutes, so it wouldnt be a very convenient drug
Additionally, there are implications for patients with CKD and those undergoing hemodialysis
"When it comes to skincare, when it comes to other injectables, Dallas is one of the top markets," Guntipalli, an internal medicine physician certified in obesity medicine, said